Recently, Sniderman et al. validated a diagnostic apolipoprotein B (apoB) algorithm derived from patients with genetically verified dyslipidemia to determine the FLL phenotypes of HLP by evaluating the conventional lipid profiles together with the plasma apoB levels [5]. The gene discussed is APOB; the disease is metabolic syndrome.